Sign Up Now to Download a Free Research Report on SVA

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts





Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Sinovac Biotech, Ltd.

Sinovac Biotech shares spiked 6.75 percent on more than double the average daily volume Monday to close at $4.11 a share. The Company has developed a portfolio of products, consisting of vaccines against the hepatitis A, hepatitis B and influenza viruses. Sinovac shares have recently been boosted by the Avian Flu (H7N9) outbreak in China.

Going forward ... (see research report)



RESEARCH REPORT ON SVA Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on